{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T04:27:09Z","timestamp":1771734429763,"version":"3.50.1"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T00:00:00Z","timestamp":1627948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s40266-021-00878-y","type":"journal-article","created":{"date-parts":[[2021,8,3]],"date-time":"2021-08-03T05:02:36Z","timestamp":1627966956000},"page":"769-791","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Use of Hormone Therapy in Postmenopausal Women with Alzheimer\u2019s Disease: A Systematic Review"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9666-0430","authenticated-orcid":false,"given":"Camila A. E. F.","family":"Cardinali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4513-7153","authenticated-orcid":false,"given":"Yandara A.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6301-3448","authenticated-orcid":false,"given":"Andr\u00e9a S.","family":"Torr\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,3]]},"reference":[{"issue":"3","key":"878_CR1","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/alz.12068","volume":"16","author":"Alzheimer\u2019s Association Report","year":"2020","unstructured":"Alzheimer\u2019s Association Report. 2020 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 2020;16(3):391\u2013460. https:\/\/doi.org\/10.1002\/alz.12068.","journal-title":"Alzheimer\u2019s Dement."},{"issue":"16","key":"878_CR2","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease: a meta-analysis. JAMA. 1997;278(16):1349\u201356.","journal-title":"JAMA"},{"issue":"4","key":"878_CR3","first-page":"225","volume":"5","author":"O Scheyer","year":"2018","unstructured":"Scheyer O, Rahman A. Female sex and Alzheimer\u2019s Risk: the menopause connection. J Prev Alzheimer\u2019s Dis. 2018;5(4):225\u201330.","journal-title":"J Prev Alzheimer\u2019s Dis."},{"key":"878_CR4","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.24135","volume":"75","author":"A Altmann","year":"2014","unstructured":"Altmann A, Tian L, Henderson VW, Greicius MD. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann Neurol. 2014;75:563\u201373.","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"878_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mce.2014.01.020","volume":"389","author":"WA Rocca","year":"2014","unstructured":"Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, estrogen, and dementia: a 2014 update. Mol Cell Endocrinol. 2014;389(1\u20132):7\u201312.","journal-title":"Mol Cell Endocrinol"},{"issue":"2","key":"878_CR6","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.trci.2015.07.001","volume":"1","author":"KA Lin","year":"2015","unstructured":"Lin KA, Choudhury KR, Rathakrishnan BG, Marks DM, Petrella JR, Doraiswamy PM. Marked gender differences in progression of mild cognitive impairment over 8 years. Alzheimer\u2019s Dement N Y. 2015;1(2):103\u201310.","journal-title":"Alzheimer\u2019s Dement N Y."},{"key":"878_CR7","doi-asserted-by":"publisher","first-page":"485","DOI":"10.2174\/1570159X18666200123165652","volume":"18","author":"H Guo","year":"2020","unstructured":"Guo H, Liu M, Zhang L, Wang L, Hou W, Ma Y, et al. The critical period for neuroprotection by estrogen replacement therapy and the potential underlying mechanisms. Curr Neuropharmacol. 2020;18:485\u2013500.","journal-title":"Curr Neuropharmacol"},{"issue":"4","key":"878_CR8","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/hipo.20935","volume":"22","author":"TC Foster","year":"2012","unstructured":"Foster TC. Role of estrogen receptor alpha and beta expression and signaling on cognitive function during aging. Hippocampus. 2012;22(4):656\u201369.","journal-title":"Hippocampus"},{"key":"878_CR9","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1001\/archpsyc.62.6.685","volume":"62","author":"LL Barnes","year":"2005","unstructured":"Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005;62:685\u201391.","journal-title":"Arch Gen Psychiatry"},{"issue":"13","key":"878_CR10","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1111\/1471-0528.12828","volume":"121","author":"J Ryan","year":"2014","unstructured":"Ryan J, Scali J, Carri\u00e8re I, Amieva H, Rouaud O, Berr C, et al. Impact of a premature menopause on cognitive function in later life. BJOG. 2014;121(13):1729\u201339.","journal-title":"BJOG"},{"key":"878_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.maturitas.2017.01.002","volume":"98","author":"B Imtiaz","year":"2017","unstructured":"Imtiaz B, Taipale H, Tanskanen A, Tiihonen M, Kivipelto M, Heikkinen AM, et al. Risk of Alzheimer\u2019s disease among users of postmenopausal hormone therapy: a nationwide case-control study. Maturitas. 2017;98:7\u201313.","journal-title":"Maturitas"},{"key":"878_CR12","doi-asserted-by":"publisher","first-page":"I665","DOI":"10.1136\/bmj.l665","volume":"364","author":"H Savolainen-Peltonen","year":"2019","unstructured":"Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, et al. Use of postmenopausal hormone therapy and risk of Alzheimer\u2019s disease in Finland: Nationwide case-control study. BMJ. 2019;364:I665.","journal-title":"BMJ"},{"key":"878_CR13","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JGP.0b013e3181beaaf4","volume":"18","author":"A Valen-Sendstad","year":"2010","unstructured":"Valen-Sendstad A, Engedal K, Stray-Pedersen B, Strobel C, Barnett L, Meyer N, et al. Effects of hormone therapy on depressive symptoms and cognitive functions in women with alzheimer disease: A 12 month randomized, double-blind, placebo-controlled study of low-dose estradiol and norethisterone. Am J Geriatr Psychiatry. 2010;18:11\u201320.","journal-title":"Am J Geriatr Psychiatry"},{"key":"878_CR14","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. PLoS Med. 2009;6:e1000097.","journal-title":"PLoS Med"},{"key":"878_CR15","doi-asserted-by":"publisher","first-page":"1000100","DOI":"10.1371\/journal.pmed.1000100","volume":"6","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA, et al. The PRISMA Statement for Reporting Systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009;6:1000100.","journal-title":"PLoS Med"},{"key":"878_CR16","unstructured":"National Health Institute. Quality Assessment Tools for Observational Cohort and Cross-Sectional Studies. 2014. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"878_CR17","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1093\/oxfordjournals.aje.a117245","volume":"140","author":"DE Brenner","year":"1994","unstructured":"Brenner DE, Kukull WA, Stergachis A, Van Belle G, Bowen JD, Mccormick WC, et al. Postmenopausal estrogen replacement therapy and the risk of alzheimer\u2019s disease: a population-based case-control study. Am J Epidemiol. 1994;140:262\u20137.","journal-title":"Am J Epidemiol"},{"key":"878_CR18","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/archneur.1994.00540210068014","volume":"51","author":"VW Henderson","year":"1994","unstructured":"Henderson VW, Paganini Hill A, Emanuel CK, Dunn ME, Buckwalter JG. Estrogen replacement therapy in older women: comparisons between alzheimer\u2019s disease cases and nondemented control subjects. Arch Neurol. 1994;51:896\u2013900.","journal-title":"Arch Neurol"},{"key":"878_CR19","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.acn.2003.09.004","volume":"19","author":"AJ Levine","year":"2004","unstructured":"Levine AJ, Battista M. Estrogen replacement therapy: effects on the cognitive functioning and clinical course of women with Alzheimer\u2019s disease. Arch Clin Neuropsychol. 2004;19:769\u201378.","journal-title":"Arch Clin Neuropsychol"},{"key":"878_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/jnnp.2003.024927","volume":"76","author":"VW Henderson","year":"2005","unstructured":"Henderson VW, Benke KS, Green RC, Cupples LA, Farrer LA. Postmenopausal hormone therapy and Alzheimer\u2019s disease risk: interaction with age. J Neurol Neurosurg Psychiatry. 2005;76:103\u20135.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"878_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1097\/00002093-200607000-00004","volume":"20","author":"RO Roberts","year":"2006","unstructured":"Roberts RO, Cha RH, Knopman DS, Petersen RC, Rocca WA. Postmenopausal estrogen therapy and Alzheimer disease: overall negative findings. Alzheimer Dis Assoc Disord. 2006;20:141\u20136.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"878_CR22","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3233\/JAD-2011-110341","volume":"26","author":"W Wharton","year":"2011","unstructured":"Wharton W, Baker LD, Gleason CE, Dowling M, Barnet JH, Johnson S, et al. Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer\u2019s disease: results of a randomized controlled trial. J Alzheimer\u2019s Dis. 2011;26:495\u2013505.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"878_CR23","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1212\/WNL.0b013e318271f823","volume":"79","author":"H Shao","year":"2012","unstructured":"Shao H, Breitner JCS, Whitmer RA, Wang J, Hayden K, Wengreen H, et al. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology. 2012;79:1846\u201352.","journal-title":"Neurology"},{"key":"878_CR24","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1097\/GME.0000000000001405","volume":"26","author":"JM Matyi","year":"2019","unstructured":"Matyi JM, Rattinger GB, Schwartz S, Buhusi M, Tschanz JT. Lifetime estrogen exposure and cognition in late life: the Cache County Study. Menopause. 2019;26:1366\u201374.","journal-title":"Menopause"},{"key":"878_CR25","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0140-6736(96)03356-9","volume":"348","author":"MX Tang","year":"1996","unstructured":"Tang MX, Jacobs D, Stern Y, Marder K, Schofieid P, Garland B, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer\u2019s disease. Lancet. 1996;348:429\u201332.","journal-title":"Lancet"},{"key":"878_CR26","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1212\/WNL.48.6.1517","volume":"48","author":"C Kawas","year":"1997","unstructured":"Kawas C, Resnick S, Morrison A, Brookmeyer R, Corrada M, Zonderman A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer\u2019s disease: the Baltimore Longitudinal Study of Aging. Neurology. 1997;48:1517\u201321.","journal-title":"Neurology"},{"key":"878_CR27","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S0306-4530(99)00020-7","volume":"24","author":"S Asthana","year":"1999","unstructured":"Asthana S, Craft S, Baker LD, Raskind MA, Birnbaum RS, Lofgreen CP, et al. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer\u2019s disease: results of a placebo- controlled, double-blind, pilot study. Psychoneuroendocrinology. 1999;24:657\u201378.","journal-title":"Psychoneuroendocrinology"},{"key":"878_CR28","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1212\/WNL.54.2.295","volume":"54","author":"VW Henderson","year":"2000","unstructured":"Henderson VW, Paganini-Hill A, Miller BL, Elble RJ, Reyes PF, Shoupe D, et al. Estrogen for Alzheimer\u2019s disease in women: randomized, double-blind, placebo-controlled trial. Neurology. 2000;54:295\u2013301.","journal-title":"Neurology"},{"key":"878_CR29","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jama.283.8.1007","volume":"283","author":"R Mulnard","year":"2000","unstructured":"Mulnard R, Cotman C, Kawas C, van Dyck CH, Sano M, Doody R, et al. Estrogen replacement therapy for treatment of mild to moderate Alzheimer Disease. JAMA. 2000;283:1007\u201315.","journal-title":"JAMA"},{"key":"878_CR30","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1212\/WNL.57.4.605","volume":"57","author":"S Asthana","year":"2001","unstructured":"Asthana S, Baker LD, Craft S, Stanczyk FZ, Veith RC, Raskind MA, et al. High-dose estradiol improves cognition for women with ad results of a randomized study. Neurology. 2001;57:605\u201312.","journal-title":"Neurology"},{"key":"878_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1001\/archneur.58.3.435","volume":"58","author":"S Seshadri","year":"2001","unstructured":"Seshadri S, Zornberg GL, Derby LE, Myers MW, Jick H, Drachman DA. Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Arch Neurol. 2001;58:435\u201340.","journal-title":"Arch Neurol"},{"key":"878_CR32","first-page":"239","volume":"11","author":"LD Baker","year":"2003","unstructured":"Baker LD, Sambamurti K, Craft S, Cherrier M, Raskind MA, Stanczyk FZ, et al. 17b-Estradiol reduces plasma Ab40 for HRT-naive postmenopausal women with Alzheimer disease. Am J Geriatr Psychiatry. 2003;11:239\u201344.","journal-title":"Am J Geriatr Psychiatry"},{"key":"878_CR33","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1212\/WNL.0000000000003696","volume":"88","author":"B Imtiaz","year":"2017","unstructured":"Imtiaz B, Tuppurainen M, Rikkonen T, Kivipelto M, Soininen H, Kr\u00f6ger H, et al. Postmenopausal hormone therapy and Alzheimer disease: a prospective cohort study. Neurology. 2017;88:1062\u20138.","journal-title":"Neurology"},{"key":"878_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1507\/endocrj.41.361","volume":"41","author":"T Ohkura","year":"1994","unstructured":"Ohkura T, Isse K, Akazawa K, Hamamoto M, Hagino N. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer type. Endocr J. 1994;41:361\u201371.","journal-title":"Endocr J"},{"key":"878_CR35","first-page":"125","volume":"1","author":"T Ohkura","year":"1994","unstructured":"Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Low-dose estrogen replacement therapy for Alzheimer disease in women. Menopause. 1994;1:125\u201330.","journal-title":"Menopause"},{"key":"878_CR36","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1212\/WNL.50.4.996","volume":"50","author":"M Baldereschi","year":"1998","unstructured":"Baldereschi M, Di Carlo A, Lepore V, Bracco L, Maggi S, Grigoletto F, et al. Estrogen-replacement therapy and Alzheimer\u2019s disease in the Italian longitudinal study on aging. Neurology. 1998;50:996\u20131002.","journal-title":"Neurology"},{"key":"878_CR37","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1136\/jnnp.67.6.779","volume":"67","author":"AJC Slooter","year":"1999","unstructured":"Slooter AJC, Bronzova J, Witteman JCM, Van Broeckhoven C, Hofman A, Van Duijn CM. Estrogen use and early onset Alzheimer\u2019s disease: a population-based study. J Neurol Neurosurg Psychiatry. 1999;67:779\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"878_CR38","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1212\/WNL.54.11.2061","volume":"54","author":"PN Wang","year":"2000","unstructured":"Wang PN, Liao SQ, Liu RS, Liu CY, Chao HT, Lu SR, et al. Effects of estrogen on cognition, mood, and cerebral blood flow in AD: a controlled study. Neurology. 2000;54:2061\u20136.","journal-title":"Neurology"},{"key":"878_CR39","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1126\/science.272.5267.1495","volume":"272","author":"X Tang","year":"1996","unstructured":"Tang X, Halleck MS, Schlegel RA, Williamson P. A subfamily of P-type ATPases with aminophospholipid transporting activity. Science. 1996;272:1495\u20137.","journal-title":"Science"},{"key":"878_CR40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.psyneuen.2008.09.008","volume":"34","author":"J Ryan","year":"2009","unstructured":"Ryan J, Carri\u00e8re I, Scali J, Ritchie K, Ancelin ML. Life-time estrogen exposure and cognitive functioning in later life. Psychoneuroendocrinology. 2009;34:287\u201398.","journal-title":"Psychoneuroendocrinology"},{"issue":"7","key":"878_CR41","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrendo.2015.82","volume":"11","author":"RD Brinton","year":"2015","unstructured":"Brinton RD, Yao J, Yin F, Mack WJ, Cadenas E. Perimenopause as a neurological transition state. Nat Rev Endocrinol. 2015;11(7):393\u2013405.","journal-title":"Nat Rev Endocrinol"},{"key":"878_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/ajhb.1310040107","volume":"4","author":"SM McKinlay","year":"1992","unstructured":"McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Am J Hum Biol. 1992;4:37\u201346.","journal-title":"Am J Hum Biol"},{"key":"878_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/humupd\/dmp037","volume":"16","author":"M Hickey","year":"2009","unstructured":"Hickey M, Ambekar M, Hammond I. Should the ovaries be removed or retained at the time of hysterectomy for benign disease? Hum Reprod Update. 2009;16:131\u201341.","journal-title":"Hum Reprod Update"},{"key":"878_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.psyneuen.2019.03.013","volume":"106","author":"MK Georgakis","year":"2019","unstructured":"Georgakis MK, Beskou-Kontou T, Theodoridis I, Skalkidou A, Petridou ET. Surgical menopause in association with cognitive function and risk of dementia: a systematic review and meta-analysis. Psychoneuroendocrinology. 2019;106:9\u201319.","journal-title":"Psychoneuroendocrinology"},{"key":"878_CR45","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1016\/j.psyneuen.2013.08.005","volume":"38","author":"M Fox","year":"2013","unstructured":"Fox M, Berzuini C, Knapp LA. Cumulative estrogen exposure, number of menstrual cycles, and Alzheimer\u2019s risk in a cohort of British women. Psychoneuroendocrinology. 2013;38:2973\u201382.","journal-title":"Psychoneuroendocrinology"},{"key":"878_CR46","doi-asserted-by":"publisher","first-page":"e10018833","DOI":"10.1371\/journal.pmed.1001833","volume":"12","author":"CE Gleason","year":"2015","unstructured":"Gleason CE, Dowling NM, Wharton W, Manson JAE, Miller VM, Atwood CS, et al. Effects of hormone therapy on cognition and mood in recently postmenopausal women: findings from the randomized, controlled KEEPS\u2013Cognitive and Affective Study. PLoS Med. 2015;12:e10018833 (discussion e1001833).","journal-title":"PLoS Med"},{"key":"878_CR47","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1001\/jama.288.3.321","volume":"288","author":"JE Rossouw","year":"2002","unstructured":"Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women\u2019s health initiative randomized controlled trial. JAMA. 2002;288:321\u201333.","journal-title":"JAMA"},{"key":"878_CR48","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson GL, Limacher M. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative Randomized Controlled Trial. JAMA. 2004;291:1701\u201312.","journal-title":"JAMA"},{"key":"878_CR49","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1001\/jama.291.24.2959","volume":"291","author":"MA Espeland","year":"2004","unstructured":"Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JAE, Sherwin BB, et al. Conjugated equine estrogens and global cognitive funtion in postmenopausal women: Women\u2019s Health Initiative Memory Study. JAMA. 2004;291:2959\u201368.","journal-title":"JAMA"},{"key":"878_CR50","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","volume":"289","author":"SA Shumaker","year":"2003","unstructured":"Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women\u2014the women\u2019s health initiative memory study: a Randomized Controlled Trial. JAMA. 2003;289:2651\u201362.","journal-title":"JAMA"},{"key":"878_CR51","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1001\/jama.291.24.2947","volume":"291","author":"SA Shumaker","year":"2004","unstructured":"Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, et al. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women\u2019s Health Initiative Memory Study. JAMA. 2004;291:2947\u201358.","journal-title":"JAMA"},{"key":"878_CR52","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/GRF.0000000000000383","volume":"61","author":"JV Pinkerton","year":"2018","unstructured":"Pinkerton JV. Hormone therapy: key points from NAMS 2017 position statement. Clin Obstet Gynecol. 2018;61:447\u201353.","journal-title":"Clin Obstet Gynecol"},{"key":"878_CR53","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S0197-4580(00)00103-2","volume":"21","author":"RB Gibbs","year":"2000","unstructured":"Gibbs RB. Long-term treatment with estrogen and progesterone enhances acquisition of a spatial memory task by ovariectomized aged rats. Neurobiol Aging. 2000;21:107\u201316.","journal-title":"Neurobiol Aging"},{"key":"878_CR54","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1212\/WNL.0000000000002980","volume":"87","author":"VW Henderson","year":"2016","unstructured":"Henderson VW, St John JA, Hodis HN, McCleary CA, Stanczyk FZ, Shoupe D, Henderson VW, St John JA, Hodis HN, et al. Cognitive effects of estradiol after menopause: a randomized trial of the timing hypothesis. Neurology. 2016;87:699\u2013708.","journal-title":"Neurology"},{"key":"878_CR55","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1365-2826.2009.01882.x","volume":"21","author":"J Bohacek","year":"2009","unstructured":"Bohacek J, Daniel JM. The ability of oestradiol administration to regulate protein levels of oestrogen receptor alpha in the hippocampus and prefrontal cortex of middle-aged rats is altered following long-term ovarian hormone deprivation. J Neuroendocrinol. 2009;21:640\u20137.","journal-title":"J Neuroendocrinol"},{"key":"878_CR56","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.brainres.2010.09.069","volume":"1379","author":"EM Waters","year":"2011","unstructured":"Waters EM, Yildirim M, Janssen WGM, Lou WYW, McEwen BS, Morrison JH, et al. Estrogen and aging affect the synaptic distribution of estrogen receptor beta-immunoreactivity in the CA1 region of female rat hippocampus. Brain Res. 2011;1379:86\u201397.","journal-title":"Brain Res"},{"key":"878_CR57","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/156720508783884611","volume":"5","author":"J Kelly","year":"2008","unstructured":"Kelly J, Bienias J, Shah A, Meeke K, Schneider J, Soriano E, et al. Levels of estrogen receptors alpha and beta in frontal cortex of patients with Alzheimers disease: relationship to mini-mental state examination scores. Curr Alzheimer Res. 2008;5:45\u201351.","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"878_CR58","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1097\/GME.0000000000000921","volume":"24","author":"The NAMS 2017 Hormone Therapy Position Statement Advisory Panel","year":"2017","unstructured":"The NAMS 2017 Hormone Therapy Position Statement Advisory Panel. The 2017 hormone therapy position statement of the North American Menopause Society. Menopause. 2017;24(7):728\u201353.","journal-title":"Menopause"},{"key":"878_CR59","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1210\/en.2009-1245","volume":"151","author":"SP Rodgers","year":"2010","unstructured":"Rodgers SP, Bohacek J, Daniel JM. Transient estradiol exposure during middle age in ovariectomized rats exerts lasting effects on cognitive function and the hippocampus. Endocrinology. 2010;151:1194\u2013203.","journal-title":"Endocrinology"},{"key":"878_CR60","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1523\/JNEUROSCI.5186-03.2004","volume":"24","author":"O Kretz","year":"2004","unstructured":"Kretz O, Fester L, Wehrenberg U, Zhou L, Brauckmann S, Zhao S, et al. Hippocampal synapses depend on hippocampal estrogen synthesis. J Neurosci. 2004;24:5913\u201321.","journal-title":"J Neurosci"},{"issue":"40","key":"878_CR61","doi-asserted-by":"publisher","first-page":"36869","DOI":"10.1074\/jbc.R100029200","volume":"276","author":"JM Hall","year":"2001","unstructured":"Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem. 2001;276(40):36869\u201372.","journal-title":"J Biol Chem"},{"key":"878_CR62","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jsbmb.2013.10.011","volume":"142","author":"BR Bhavnani","year":"2014","unstructured":"Bhavnani BR, Stanczyk FZ. Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action. J Steroid Biochem Mol Biol. 2014;142:16\u201329.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"3","key":"878_CR63","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00018-004-4385-z","volume":"62","author":"CE Gleason","year":"2005","unstructured":"Gleason CE, Cholerton B, Carlsson CM, Johnson SC, Asthana S. Neuroprotective effects of female sex steroids in humans: current controversies and future directions. Cell Mol Life Sci. 2005;62(3):299\u2013312.","journal-title":"Cell Mol Life Sci"},{"key":"878_CR64","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.maturitas.2003.11.009","volume":"47","author":"BH Coelingh","year":"2004","unstructured":"Coelingh BH. Are all estrogens the same? Maturitas. 2004;47:269\u201375.","journal-title":"Maturitas"},{"issue":"6","key":"878_CR65","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.coph.2008.10.002","volume":"8","author":"M Schumacher","year":"2008","unstructured":"Schumacher M, Sitruk-Ware R, De Nicola AF. Progesterone and progestins: neuroprotection and myelin repair. Curr Opin Pharmacol. 2008;8(6):740\u20136.","journal-title":"Curr Opin Pharmacol"},{"issue":"7","key":"878_CR66","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1517\/13543784.2010.489549","volume":"19","author":"DG Stein","year":"2010","unstructured":"Stein DG, Wright DW. Progesterone in the clinical treatment of acute traumatic brain injury. Expert Opin Investig Drugs. 2010;19(7):847\u201357.","journal-title":"Expert Opin Investig Drugs"},{"key":"878_CR67","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/bmj.39555.441944.BE","volume":"336","author":"M Canonico","year":"2008","unstructured":"Canonico M, Plu-Bureau G, Lowe GDO, Scarabin PY. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. BMJ. 2008;336:1227\u201331.","journal-title":"BMJ"},{"key":"878_CR68","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jsbmb.2015.08.013","volume":"153","author":"FZ Stanczyk","year":"2015","unstructured":"Stanczyk FZ, Bhavnani BR. Reprint of \u201cUse of medroxyprogesterone acetate for hormone therapy in postmenopausal women: Is it safe?\u201d J Steroid Biochem Mol Biol. 2015;153:151\u20139.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"878_CR69","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1111\/j.1538-7836.2012.04919.x","volume":"10","author":"S Sweetland","year":"2012","unstructured":"Sweetland S, Beral V, Balkwill A, Liu B, Benson VS, Canonico M, et al. Venous thromboembolism risk in relation to use of different types of postmenopausal hormone therapy in a large prospective study. J Thromb Haemost. 2012;10:2277\u201386.","journal-title":"J Thromb Haemost"},{"key":"878_CR70","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1037\/0735-7044.120.4.905","volume":"120","author":"A Garza-Meilandt","year":"2006","unstructured":"Garza-Meilandt A, Cantu RE, Claiborne BJ. Estradiol\u2019s effects on learning and neuronal morphology vary with route of administration. Behav Neurosci. 2006;120:905\u201316.","journal-title":"Behav Neurosci"},{"key":"878_CR71","first-page":"758","volume":"77","author":"RT Scott","year":"1991","unstructured":"Scott RT, Ross B, Anderson C, Archer DF. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol. Obstet Gynecol. 1991;77:758\u201364.","journal-title":"Obstet Gynecol"},{"key":"878_CR72","first-page":"766","volume":"46","author":"I Setnikar","year":"1996","unstructured":"Setnikar I, Rovati L, Vens-Cappell B, Hilgenstock C. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol. Arzneimittelforschung. 1996;46:766\u201373.","journal-title":"Arzneimittelforschung"},{"key":"878_CR73","first-page":"1052","volume":"46","author":"CC Slater","year":"2001","unstructured":"Slater CC, Zhang C, Hodis HN, Mack WJ, Boostanfar R, Shoupe D, et al. Comparison of estrogen and androgen levels after oral estrogen replacement therapy. J Reprod Med. 2001;46:1052\u20136.","journal-title":"J Reprod Med"},{"key":"878_CR74","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3109\/09513590.2012.730567","volume":"29","author":"I Po\u0142a\u0107","year":"2013","unstructured":"Po\u0142a\u0107 I, Borowiecka M, Wilamowska A, Nowak P. Coagulation and fibrynolitic parameters in women and the effects of hormone therapy; Comparison of transdermal and oral administration. Gynecol Endocrinol. 2013;29:165\u20138.","journal-title":"Gynecol Endocrinol"},{"key":"878_CR75","first-page":"1371","volume":"18","author":"C Steunkel","year":"2011","unstructured":"Steunkel C, Gass M. Results from 2010 NAMS Survey on secondary transfer of transdermal estrogen preparations. Menopause. 2011;18:1371.","journal-title":"Menopause"},{"key":"878_CR76","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1097\/GME.0000000000000590","volume":"23","author":"JA Simon","year":"2016","unstructured":"Simon JA, Lalibert\u00e9 F, Duh MS, Pilon D, Kahler KH, Nyirady J, et al. Venous thromboembolism and cardiovascular disease complications in menopausal women using transdermal versus oral estrogen therapy. Menopause. 2016;23:600\u201310.","journal-title":"Menopause"},{"issue":"7","key":"878_CR77","first-page":"525","volume":"48","author":"MR Henzl","year":"2003","unstructured":"Henzl MR, Loomba PK. Transdermal delivery of sex steroids for hormone replacement therapy and contraception: a review of principles and practice. J Reprod Med. 2003;48(7):525\u201340.","journal-title":"J Reprod Med"},{"key":"878_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0015-0282(01)03275-7","volume":"77","author":"M Zieman","year":"2002","unstructured":"Zieman M, Guillebaud J, Weisberg E, Shangold GA, Fisher AC, Creasy GW. Contraceptive efficacy and cycle control with the Ortho EvraTM\/EvraTM transdermal system: the analysis of pooled data. Fertil Steril. 2002;77:13\u20138.","journal-title":"Fertil Steril"},{"key":"878_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.fertnstert.2004.01.025","volume":"82","author":"NJ Alexander","year":"2004","unstructured":"Alexander NJ, Baker E, Kaptein M, Karck U, Miller L, Zampaglione E. Why consider vaginal drug administration? Fertil Steril. 2004;82:1\u201312.","journal-title":"Fertil Steril"},{"issue":"6 Pt 1","key":"878_CR80","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/S0002-9378(99)70042-6","volume":"180","author":"DE Tourgeman","year":"1999","unstructured":"Tourgeman DE, Gentzchein E, Stanczyk FZ, Paulson RJ. Serum and tissue hormone levels of vaginally and orally administered estradiol. Am J Obstet Gynecol. 1999;180(6 Pt 1):1480\u20133.","journal-title":"Am J Obstet Gynecol"},{"key":"878_CR81","unstructured":"Derendorf H, Schmidt S. Rowland and Tozer's clinical pharmacokinetics and pharmacodynamics: concepts and applications. 3rd ed. Philadelphia: Lippincott Williams and Wilkins; 1995."},{"key":"878_CR82","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/gme.0b013e31824b970a","volume":"19","author":"MLS Gass","year":"2012","unstructured":"Gass MLS, Manson JE, Cosman F, Grodstein F, Craig Jordan V, Karas RH, et al. The 2012 hormone therapy position statement of the North American Menopause Society. Menopause. 2012;19:257\u201371.","journal-title":"Menopause"},{"key":"878_CR83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainres.2013.04.011","volume":"1514","author":"W Wharton","year":"2013","unstructured":"Wharton W, Gleason CE, Miller VM, Asthana S. Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS cognitive and affective sub study (KEEPS Cog). Brain Res. 2013;1514:12\u20137.","journal-title":"Brain Res"},{"issue":"7","key":"878_CR84","doi-asserted-by":"publisher","first-page":"501","DOI":"10.7326\/0003-4819-140-7-200404060-00008","volume":"140","author":"EB Larson","year":"2004","unstructured":"Larson EB, Shadlen MF, Wang L, McCormick WC, Bowen JD, Teri L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med. 2004;140(7):501\u20139.","journal-title":"Ann Intern Med"},{"issue":"6","key":"878_CR85","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","volume":"13","author":"B Dubois","year":"2014","unstructured":"Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JL, Blennow K, et al. Advancing research diagnostic criteria for Alzheimer\u2019s disease: the IWG-2 criteria. Lancet Neurol. 2014;13(6):614\u201329.","journal-title":"Lancet Neurol"},{"key":"878_CR86","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of department of health and human services task force on alzheimer\u2019s disease. Neurology. 1984;34:939\u201344.","journal-title":"Neurology"},{"key":"878_CR87","first-page":"CD005593","volume":"1","author":"J Birks","year":"2006","unstructured":"Birks J. Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2006;1:CD005593.","journal-title":"Cochrane Database Syst Rev"},{"key":"878_CR88","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1046\/j.1471-4159.1999.721552.x","volume":"72","author":"CJ Pike","year":"1999","unstructured":"Pike CJ. Estrogen modulates neuronal Bcl-x(L) expression and \u03b2-amyloid-induced apoptosis: Relevance to Alzheimer\u2019s disease. J Neurochem J Neurochem. 1999;72:1552\u201363.","journal-title":"J Neurochem J Neurochem."},{"key":"878_CR89","first-page":"10","volume":"12","author":"M Simard","year":"1998","unstructured":"Simard M. The mini-mental state examination: strengths and weaknesses of a clinical instrument. Can Alzheimer Dis Rev. 1998;12:10\u20132.","journal-title":"Can Alzheimer Dis Rev."},{"key":"878_CR90","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1212\/01.WNL.0000069923.64550.9F","volume":"60","author":"DA Bennett","year":"2003","unstructured":"Bennett DA, Wilson RS, Schneider JA, Evans DA, de Leon CFM, Arnold SE, et al. Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology. 2003;60:1909\u201315.","journal-title":"Neurology"},{"key":"878_CR91","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0014-4886(03)00215-2","volume":"183","author":"RG Struble","year":"2003","unstructured":"Struble RG, Rosario ER, Kircher ML, Ludwig SM, McAdamis PJ, Watabe K, et al. Regionally specific modulation of brain apolipoprotein E in the mouse during the estrous cycle and by exogenous 17\u03b2 estradiol. Exp Neurol. 2003;183:638\u201344.","journal-title":"Exp Neurol"},{"key":"878_CR92","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.neurobiolaging.2007.04.018","volume":"29","author":"CM Brown","year":"2008","unstructured":"Brown CM, Choi E, Xu Q, Vitek MP, Colton CA. The APOE4 genotype alters the response of microglia and macrophages to 17\u03b2-estradiol. Neurobiol Aging. 2008;29:1783\u201394.","journal-title":"Neurobiol Aging"},{"key":"878_CR93","doi-asserted-by":"publisher","first-page":"13357","DOI":"10.1523\/JNEUROSCI.2718-07.2007","volume":"27","author":"JC Carroll","year":"2007","unstructured":"Carroll JC, Rosario ER, Chang L, Stanczyk FZ, Oddo S, LaFerla FM, et al. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J Neurosci. 2007;27:13357\u201365.","journal-title":"J Neurosci"},{"key":"878_CR94","doi-asserted-by":"publisher","first-page":"19198","DOI":"10.1073\/pnas.0505203102","volume":"102","author":"X Yue","year":"2005","unstructured":"Yue X, Lu M, Lancaster T, Cao P, Honda SI, Staufenbiel M, et al. Brain estrogen deficiency accelerates A\u03b2 plaque formation in an Alzheimer\u2019s disease animal model. Proc Natl Acad Sci USA. 2005;102:19198\u2013203.","journal-title":"Proc Natl Acad Sci USA"},{"key":"878_CR95","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.neulet.2013.12.032","volume":"560","author":"J Kunzler","year":"2014","unstructured":"Kunzler J, Youmans KL, Yu C, LaDu MJ, Tai LM. APOE modulates the effect of estrogen therapy on A\u03b2 accumulation EFAD-Tg mice. Neurosci Lett. 2014;560:131\u20136.","journal-title":"Neurosci Lett"},{"key":"878_CR96","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1212\/WNL.54.10.1949","volume":"54","author":"K Yaffe","year":"2000","unstructured":"Yaffe K, Haan M, Byers A, Tangen C, Kuller L. Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction. Neurology. 2000;54:1949\u201353.","journal-title":"Neurology"},{"key":"878_CR97","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1016\/j.neurobiolaging.2010.10.007","volume":"33","author":"JH Kang","year":"2012","unstructured":"Kang JH, Grodstein F. Postmenopausal hormone therapy, timing of initiation. APOE and cognitive decline. Neurobiol Aging. 2012;33:1129\u201337.","journal-title":"Neurobiol Aging"},{"key":"878_CR98","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3233\/JAD-2004-6302","volume":"6","author":"MS Burkhardt","year":"2004","unstructured":"Burkhardt MS, Foster JK, Laws SM, Baker LD, Craft S, Gandy SE, et al. Oestrogen replacement therapy may improve memory functioning in the absence of APOE \u03b54. J Alzheimer\u2019s Dis. 2004;6:221\u20138.","journal-title":"J Alzheimer\u2019s Dis."},{"key":"878_CR99","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/gerona\/59.1.B16","volume":"59","author":"D Ewbank","year":"2004","unstructured":"Ewbank D. The APOE gene and differences in life expectancy in Europe. J Gerontol A Biol Sci Med Sci. 2004;59:16\u201320.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"11","key":"878_CR100","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/S1474-4422(12)70191-6","volume":"11","author":"Y Stern","year":"2012","unstructured":"Stern Y. Cognitive reserve in ageing and Alzheimer\u2019s disease. Lancet Neurol. 2012;11(11):1006\u201312.","journal-title":"Lancet Neurol"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00878-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-021-00878-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00878-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T03:25:20Z","timestamp":1630898720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-021-00878-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,3]]},"references-count":100,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["878"],"URL":"https:\/\/doi.org\/10.1007\/s40266-021-00878-y","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,3]]},"assertion":[{"value":"8 June 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the conduct or publication of this systematic review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Camila A.E.F. Cardinali, Yandara A. Martins and Andr\u00e9a S. Torr\u00e3o declare they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"All authors contributed significantly to the study conception and design. Material preparation, data collection and extraction were performed by Camila A.E.F. Cardinali and Yandara A. Martins. Andr\u00e9a S. Torr\u00e3o contributed to manuscript conception, preparation and correction. All authors participated in the conception of the manuscript and read and approved the final version.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}